Results 211 to 220 of about 2,074,197 (379)
Retraction: Specific inhibition of tumor cells by oncogenic EGFR specific silencing by RNA interference. [PDF]
PLOS One Editors.
europepmc +1 more source
RNA Interference Gene Therapy: A story of mice and men [PDF]
Anton P. McCaffrey, Mark A. Kay
openalex +1 more source
RNA Interference to Knock Down Gene Expression.
Haiyong Han
semanticscholar +1 more source
Compound Heterozygous MRPS14 Variants Associated With Leigh Syndrome
ABSTRACT MRPS14 (uS14m) is a nuclear‐encoded ribosomal protein important for mitochondria‐specific translation. To date, only a single individual with a recessive MRPS14‐related disorder (also known as COXPD38) has been reported. We report an additional subject possessing novel compound heterozygous MRPS14 variants (p.Asp37Asn, p.Asn60Asp). The subject
Maria Gabriela Otero+15 more
wiley +1 more source
RNA Interference Applied to Crustacean Aquaculture. [PDF]
Fajardo C+8 more
europepmc +1 more source
Hypoxia promotes the epithelial‐mesenchymal transition (EMT) of renal tubular epithelial cells via the SIRT1‐FoxO1‐FoxO3‐autophagy pathway, thereby resulting in the fibrosis of renal tubular epithelial cells. Activation of SIRT1 or induction of autophagy inhibits this process, alleviating hypoxia‐induced fibrosis.
Guangyu Wang+6 more
wiley +1 more source
NS3 of hepatitis C virus drives hepatocellular carcinoma progression through a novel RNA-interference pathway. [PDF]
Liang Y, Luo J, Hu L, Zhang J.
europepmc +1 more source
The Mechanism of RNA Interference and the Transposon Silencing inCaenorhabditis elegans [PDF]
Marcel Tijsterman+8 more
openalex +1 more source
Extracellular vesicles (EVs) play a dual role in diagnostics and therapeutics, offering innovative solutions for treating cancer, cardiovascular, neurodegenerative, and orthopedic diseases. This review highlights EVs’ potential to revolutionize personalized medicine through specific applications in disease detection and treatment.
Farbod Ebrahimi+4 more
wiley +1 more source